1. Home
  2. CADL vs PUBM Comparison

CADL vs PUBM Comparison

Compare CADL & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.65

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Logo PubMatic Inc.

PUBM

PubMatic Inc.

HOLD

Current Price

$17.65

Market Cap

587.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
PUBM
Founded
1999
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
694.6M
587.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CADL
PUBM
Price
$10.65
$17.65
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$19.00
$12.43
AVG Volume (30 Days)
1.1M
598.8K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
$282,926,000.00
Revenue This Year
N/A
$3.44
Revenue Next Year
N/A
$7.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$6.15
52 Week High
$11.36
$18.44

Technical Indicators

Market Signals
Indicator
CADL
PUBM
Relative Strength Index (RSI) 60.63 78.45
Support Level $9.18 $8.85
Resistance Level $11.36 N/A
Average True Range (ATR) 0.47 0.61
MACD 0.04 0.50
Stochastic Oscillator 87.00 85.00

Price Performance

Historical Comparison
CADL
PUBM

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About PUBM PubMatic Inc.

PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.

Share on Social Networks: